Clinical standards for drug-susceptible TB: putting patients first.

van der Werf, T S; Grobusch, M P

van der Werf, T S; Grobusch, M P.

van der Werf TS; Department of 1Internal Medicine, Division of Infectious Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands, Department of Pulmonary Diseases & Tuberculosis, Division of Infectious Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Grobusch MP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam Infection and Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands, Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Centre de Recherches Médicales en Lambaréné, Lambaréné, Gabon, Masanga Medical Resea

Int J Tuberc Lung Dis ; 26(7): 584-586, 2022 07 01.

Article in English | MEDLINE | ID: covidwho-1988337

Subject(s)

Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Antitubercular Agents/therapeutic use; Humans; Tuberculosis, Multidrug-Resistant/drug therapy; Tuberculosis, Multidrug-Resistant/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Mycobacterium tuberculosis Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Int J Tuberc Lung Dis Year: 2022 Document Type: Article Affiliation country: IJTLD.22.0240

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google